CYCLOALKANOPYRIDINES, PROCESS OF THEIR PREPARATION, PHARMACEUTICAL COMPOSITIONS CONTAINING THEREOF AND THEIR USE
Cycloalkano-pyridine compounds of formula (I) and their salts and N-oxides are new. A = 6-10C aryl (optionally up to penta-substituted by halo, NO2, OH, CF3, OCF3, 1-7C alkyl, 1-7C acyl, 1-7C hydroxyalkyl, 1-7C alkoxy or NR3R4); R3, R4 = H, phenyl or 1-6C alkyl; D = 6-10C aryl (optionally substitute...
Gespeichert in:
| Hauptverfasser: | , , , , , , , , , , , , , , |
|---|---|
| Format: | Patent |
| Sprache: | cze ; eng |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | SCHMIDT DELF DR CONRAD MICHAEL DR BRANDES ARNDT DR ANGERBAUER ROLF DR SCHMECK CARSTEN DR GIERA HENRY DR NAAB PAUL DR BREMM KLAUS DIETER DR LOGERS MICHAEL DR MULLER-GLIEMANN MATTHIAS DR STOLTEFUSS JURGEN BISCHOFF HILMAR DR SCHMIDT GUNTER DR SCHUHMACHER JOACHIM DR PAULSEN HOLGER DR |
| description | Cycloalkano-pyridine compounds of formula (I) and their salts and N-oxides are new. A = 6-10C aryl (optionally up to penta-substituted by halo, NO2, OH, CF3, OCF3, 1-7C alkyl, 1-7C acyl, 1-7C hydroxyalkyl, 1-7C alkoxy or NR3R4); R3, R4 = H, phenyl or 1-6C alkyl; D = 6-10C aryl (optionally substituted by phenyl, halo, NO2, CF3 or OCF3), LR5, C(R6)(R7)R8 or XVTR9; R9 = 3-6C cycloalkyl, 6-10C aryl or 5-7 membered, optionally benzo-condensed, optionally unsaturated mono- bi or tri-cyclic heterocycle with 1-4 S, N and/or O (all optionally up to penta-substituted by halo, NO2, OH, CF3, CN, COOH, OCF3, 1-6C alkyl, 1-6C acyl, 1-6C alkylthio, 1-6C alkoxy or alkoxycarbonyl, 6-10C aryl (optionally substituted by aryl or CF3) or 5-7 membered, optionally benzo-condensed, heteroaryl with 1-3 N, O and/or S heteroatoms), and/or OR10, SR11, SO2R12 or NR13, R14; R10-R12 = 6-10C aryl (optionally mono- to di-substituted, by phenyl, halo or 1-6C alkyl); R5, R6 = as for R9 or a group of formula (a) or (b); R7 = H or halo; R8 = H, halo, N3, CF3, OH, OCF3, 1-6C alkoxy, 1-6C alkyl or NR15R16; or R7+R8 = O or NR17; R17 = H, 1-6C alkyl, 1-6C acyl or 1-6C alkoxy; L = 1-8C alkylene or 2-8C alkenylene (both optionally mono- or di- substituted by OH); T, X = bond or 1-8C alkylene, provided they are not both a bond; V = O, S or NR18; R13-R16, R18 = as R3, R4; E = 3-8C cycloalkyl, 1-8C alkyl (optionally substituted by 3-8C cycloalkyl or OH) or phenyl (optionally substituted by halo or CF3); R1+R2 = 1-7C alkylene substituted by carbonyl and/or Z, and optionally also geminal, optionally substituted by up to 6 Z' and/or up to 5 Z", and/or 1,2-(CH2)c, SO2C6H5, (CO)dNR23R24 or O; and/or a spiro-bonded group Zb of formula (g)-(k); Z = OR19, or a group of formula (c)-(f); a, b = 1-3; R19 = H, 3-7C cycloalkyl, up to 8C silylalkyl, 1-8C alkyl (optionally substituted by OH, 1-6C alkoxy or Ar), (where alkyl is optionally substituted by OR22) ÄsicÜ, 1-20C acyl or benzoyl (optionally substituted by halo, CF3, NO2 or OCF3) or 1-8C fluoroacyl (with 1-9F); R20, R21 = H, phenyl or 1-6C alkyl; or R20+R21 = 3-6C cycloalkyl; Z" = phenyl, benzoyl, thiophenyl or sulphonylbenzyl (all optionally substituted by halo, CF3, OCF3 or NO2); Z' = halo, NO2, N3, OH, CF3, CN, NC, COOH, 3-7C cycloalkyl, 3-7C cycloalkyloxy, 1-6C alkyl (optionally mono- or di-substituted by OH, benzyloxy, CF3, benzoyl, alkoxy, oxyacyl or carboxy each with 1-4C, and/or phenyl (itself optionally substituted by halo, CF3 or OCF3)), 1-6C alkylt |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_CZ214397A3</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>CZ214397A3</sourcerecordid><originalsourceid>FETCH-epo_espacenet_CZ214397A33</originalsourceid><addsrcrecordid>eNqFjLEKwkAQRNNYiPoN3gdooRHEctlszGJye9xditiEIGclehD_Hy-Q3mqYeTOzzCJ2WAvUN9BiOssFa3I7ZawgOaekVL4itikgAxY8i060AtsAUusZoVYojRHHE3PJaA-sWV-npaX0ALqYX1pH62zxHF5j2My6yrYleaz2IX76MMbhEd7h2-P9eDjllzPk-f_GD1JaN5Y</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>CYCLOALKANOPYRIDINES, PROCESS OF THEIR PREPARATION, PHARMACEUTICAL COMPOSITIONS CONTAINING THEREOF AND THEIR USE</title><source>esp@cenet</source><creator>SCHMIDT DELF DR ; CONRAD MICHAEL DR ; BRANDES ARNDT DR ; ANGERBAUER ROLF DR ; SCHMECK CARSTEN DR ; GIERA HENRY DR ; NAAB PAUL DR ; BREMM KLAUS DIETER DR ; LOGERS MICHAEL DR ; MULLER-GLIEMANN MATTHIAS DR ; STOLTEFUSS JURGEN ; BISCHOFF HILMAR DR ; SCHMIDT GUNTER DR ; SCHUHMACHER JOACHIM DR ; PAULSEN HOLGER DR</creator><creatorcontrib>SCHMIDT DELF DR ; CONRAD MICHAEL DR ; BRANDES ARNDT DR ; ANGERBAUER ROLF DR ; SCHMECK CARSTEN DR ; GIERA HENRY DR ; NAAB PAUL DR ; BREMM KLAUS DIETER DR ; LOGERS MICHAEL DR ; MULLER-GLIEMANN MATTHIAS DR ; STOLTEFUSS JURGEN ; BISCHOFF HILMAR DR ; SCHMIDT GUNTER DR ; SCHUHMACHER JOACHIM DR ; PAULSEN HOLGER DR</creatorcontrib><description>Cycloalkano-pyridine compounds of formula (I) and their salts and N-oxides are new. A = 6-10C aryl (optionally up to penta-substituted by halo, NO2, OH, CF3, OCF3, 1-7C alkyl, 1-7C acyl, 1-7C hydroxyalkyl, 1-7C alkoxy or NR3R4); R3, R4 = H, phenyl or 1-6C alkyl; D = 6-10C aryl (optionally substituted by phenyl, halo, NO2, CF3 or OCF3), LR5, C(R6)(R7)R8 or XVTR9; R9 = 3-6C cycloalkyl, 6-10C aryl or 5-7 membered, optionally benzo-condensed, optionally unsaturated mono- bi or tri-cyclic heterocycle with 1-4 S, N and/or O (all optionally up to penta-substituted by halo, NO2, OH, CF3, CN, COOH, OCF3, 1-6C alkyl, 1-6C acyl, 1-6C alkylthio, 1-6C alkoxy or alkoxycarbonyl, 6-10C aryl (optionally substituted by aryl or CF3) or 5-7 membered, optionally benzo-condensed, heteroaryl with 1-3 N, O and/or S heteroatoms), and/or OR10, SR11, SO2R12 or NR13, R14; R10-R12 = 6-10C aryl (optionally mono- to di-substituted, by phenyl, halo or 1-6C alkyl); R5, R6 = as for R9 or a group of formula (a) or (b); R7 = H or halo; R8 = H, halo, N3, CF3, OH, OCF3, 1-6C alkoxy, 1-6C alkyl or NR15R16; or R7+R8 = O or NR17; R17 = H, 1-6C alkyl, 1-6C acyl or 1-6C alkoxy; L = 1-8C alkylene or 2-8C alkenylene (both optionally mono- or di- substituted by OH); T, X = bond or 1-8C alkylene, provided they are not both a bond; V = O, S or NR18; R13-R16, R18 = as R3, R4; E = 3-8C cycloalkyl, 1-8C alkyl (optionally substituted by 3-8C cycloalkyl or OH) or phenyl (optionally substituted by halo or CF3); R1+R2 = 1-7C alkylene substituted by carbonyl and/or Z, and optionally also geminal, optionally substituted by up to 6 Z' and/or up to 5 Z", and/or 1,2-(CH2)c, SO2C6H5, (CO)dNR23R24 or O; and/or a spiro-bonded group Zb of formula (g)-(k); Z = OR19, or a group of formula (c)-(f); a, b = 1-3; R19 = H, 3-7C cycloalkyl, up to 8C silylalkyl, 1-8C alkyl (optionally substituted by OH, 1-6C alkoxy or Ar), (where alkyl is optionally substituted by OR22) ÄsicÜ, 1-20C acyl or benzoyl (optionally substituted by halo, CF3, NO2 or OCF3) or 1-8C fluoroacyl (with 1-9F); R20, R21 = H, phenyl or 1-6C alkyl; or R20+R21 = 3-6C cycloalkyl; Z" = phenyl, benzoyl, thiophenyl or sulphonylbenzyl (all optionally substituted by halo, CF3, OCF3 or NO2); Z' = halo, NO2, N3, OH, CF3, CN, NC, COOH, 3-7C cycloalkyl, 3-7C cycloalkyloxy, 1-6C alkyl (optionally mono- or di-substituted by OH, benzyloxy, CF3, benzoyl, alkoxy, oxyacyl or carboxy each with 1-4C, and/or phenyl (itself optionally substituted by halo, CF3 or OCF3)), 1-6C alkylthio, 1-6C alkoxy or alkoxycarbonyl; R22 = 1-4C acyl or benzyl; Ar = phenyl (optionally substituted by halo, NO2, CF3, OCF3 or phenyl- or tetrazolyl-substituted phenyl); c = 1-4; d = 0 or 1; R23, R24 = H, 3-6C cycloalkyl, 1-6C alkyl, benzyl or phenyl (optionally mono- or di-substituted by halo, CF3, CN, phenyl or NO2); W= O or S; Y+Y' = 2-6C alkylene; e = 1-7; f = 1 or 2; R25-R31 = H, CF3, phenyl, halo, 1-6C alkyl or 1-6C alkoxy; or R25+R26 or R27+R28 = 1-6C alkylene or W-(CH2)h-W; h = 2-8; R32+R33 = 3-7-membered heterocycle containing O, S, SO, SO2 or NR34; R34 = H, phenyl, benzyl or 1-4C alkyl. Also claimed are the following intermediates: 3-amino-3-cyclopentyl-1-(4-trifluoromethylphenyl)propenone; 2-cyclopentyl-4-(4-fluorophenyl)-7,7-dimethyl-3-(trifluoromethylbenzoy l)-4,6,7,8-tetrahydro-1H-quinolin-5-one; 2-cyclopentyl-4-(4-fluorophenyl)-7,7-dimethyl-3-(4-trifluoromethylbenz oyl)-7,8-dihydro-6H-quinolin-5-one; Ä2-cyclopentyl-4-(4-fluorophenyl)-5-hydroxy-7,7-dimethyl-5,6,7,8-tetra hydroquinolin-3-ylÜ- (4-trifluoromethylphenyl)-methanone; Ä5-(tert. butyldimethylsilanyloxy)-2-cyclopentyl-4-(4-fluorophenyl)-7,7-dimethyl -5,6,7,8-tetrahydroquinolin-3-ylÜ-(4-trifluoromethylphenyl)-me thanone; Ä5-(tert. butyldimethylsilanyloxy)-2-cyclopentyl-4-(4-fluorophenyl)-7,7-dimethyl -5,6,7,8-tetrahydroquinolin-3-ylÜ-(4-trifluoromethylphenyl)-me thanol; and 5-(tert. butyldimethylsilanyloxy)-2-cyclopentyl-4-(4-fluorophenyl)-3-Äfluoro-(4 -trifluoromethylphenyl)-methylÜ-7,7-dimethyl-5,6,7,8-tetrahydr oquinoline.</description><edition>6</edition><language>cze ; eng</language><subject>ACYCLIC OR CARBOCYCLIC COMPOUNDS ; ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAININGELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN,SULFUR, SELENIUM OR TELLURIUM ; CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>1998</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=19980114&DB=EPODOC&CC=CZ&NR=214397A3$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,777,882,25545,76296</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=19980114&DB=EPODOC&CC=CZ&NR=214397A3$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>SCHMIDT DELF DR</creatorcontrib><creatorcontrib>CONRAD MICHAEL DR</creatorcontrib><creatorcontrib>BRANDES ARNDT DR</creatorcontrib><creatorcontrib>ANGERBAUER ROLF DR</creatorcontrib><creatorcontrib>SCHMECK CARSTEN DR</creatorcontrib><creatorcontrib>GIERA HENRY DR</creatorcontrib><creatorcontrib>NAAB PAUL DR</creatorcontrib><creatorcontrib>BREMM KLAUS DIETER DR</creatorcontrib><creatorcontrib>LOGERS MICHAEL DR</creatorcontrib><creatorcontrib>MULLER-GLIEMANN MATTHIAS DR</creatorcontrib><creatorcontrib>STOLTEFUSS JURGEN</creatorcontrib><creatorcontrib>BISCHOFF HILMAR DR</creatorcontrib><creatorcontrib>SCHMIDT GUNTER DR</creatorcontrib><creatorcontrib>SCHUHMACHER JOACHIM DR</creatorcontrib><creatorcontrib>PAULSEN HOLGER DR</creatorcontrib><title>CYCLOALKANOPYRIDINES, PROCESS OF THEIR PREPARATION, PHARMACEUTICAL COMPOSITIONS CONTAINING THEREOF AND THEIR USE</title><description>Cycloalkano-pyridine compounds of formula (I) and their salts and N-oxides are new. A = 6-10C aryl (optionally up to penta-substituted by halo, NO2, OH, CF3, OCF3, 1-7C alkyl, 1-7C acyl, 1-7C hydroxyalkyl, 1-7C alkoxy or NR3R4); R3, R4 = H, phenyl or 1-6C alkyl; D = 6-10C aryl (optionally substituted by phenyl, halo, NO2, CF3 or OCF3), LR5, C(R6)(R7)R8 or XVTR9; R9 = 3-6C cycloalkyl, 6-10C aryl or 5-7 membered, optionally benzo-condensed, optionally unsaturated mono- bi or tri-cyclic heterocycle with 1-4 S, N and/or O (all optionally up to penta-substituted by halo, NO2, OH, CF3, CN, COOH, OCF3, 1-6C alkyl, 1-6C acyl, 1-6C alkylthio, 1-6C alkoxy or alkoxycarbonyl, 6-10C aryl (optionally substituted by aryl or CF3) or 5-7 membered, optionally benzo-condensed, heteroaryl with 1-3 N, O and/or S heteroatoms), and/or OR10, SR11, SO2R12 or NR13, R14; R10-R12 = 6-10C aryl (optionally mono- to di-substituted, by phenyl, halo or 1-6C alkyl); R5, R6 = as for R9 or a group of formula (a) or (b); R7 = H or halo; R8 = H, halo, N3, CF3, OH, OCF3, 1-6C alkoxy, 1-6C alkyl or NR15R16; or R7+R8 = O or NR17; R17 = H, 1-6C alkyl, 1-6C acyl or 1-6C alkoxy; L = 1-8C alkylene or 2-8C alkenylene (both optionally mono- or di- substituted by OH); T, X = bond or 1-8C alkylene, provided they are not both a bond; V = O, S or NR18; R13-R16, R18 = as R3, R4; E = 3-8C cycloalkyl, 1-8C alkyl (optionally substituted by 3-8C cycloalkyl or OH) or phenyl (optionally substituted by halo or CF3); R1+R2 = 1-7C alkylene substituted by carbonyl and/or Z, and optionally also geminal, optionally substituted by up to 6 Z' and/or up to 5 Z", and/or 1,2-(CH2)c, SO2C6H5, (CO)dNR23R24 or O; and/or a spiro-bonded group Zb of formula (g)-(k); Z = OR19, or a group of formula (c)-(f); a, b = 1-3; R19 = H, 3-7C cycloalkyl, up to 8C silylalkyl, 1-8C alkyl (optionally substituted by OH, 1-6C alkoxy or Ar), (where alkyl is optionally substituted by OR22) ÄsicÜ, 1-20C acyl or benzoyl (optionally substituted by halo, CF3, NO2 or OCF3) or 1-8C fluoroacyl (with 1-9F); R20, R21 = H, phenyl or 1-6C alkyl; or R20+R21 = 3-6C cycloalkyl; Z" = phenyl, benzoyl, thiophenyl or sulphonylbenzyl (all optionally substituted by halo, CF3, OCF3 or NO2); Z' = halo, NO2, N3, OH, CF3, CN, NC, COOH, 3-7C cycloalkyl, 3-7C cycloalkyloxy, 1-6C alkyl (optionally mono- or di-substituted by OH, benzyloxy, CF3, benzoyl, alkoxy, oxyacyl or carboxy each with 1-4C, and/or phenyl (itself optionally substituted by halo, CF3 or OCF3)), 1-6C alkylthio, 1-6C alkoxy or alkoxycarbonyl; R22 = 1-4C acyl or benzyl; Ar = phenyl (optionally substituted by halo, NO2, CF3, OCF3 or phenyl- or tetrazolyl-substituted phenyl); c = 1-4; d = 0 or 1; R23, R24 = H, 3-6C cycloalkyl, 1-6C alkyl, benzyl or phenyl (optionally mono- or di-substituted by halo, CF3, CN, phenyl or NO2); W= O or S; Y+Y' = 2-6C alkylene; e = 1-7; f = 1 or 2; R25-R31 = H, CF3, phenyl, halo, 1-6C alkyl or 1-6C alkoxy; or R25+R26 or R27+R28 = 1-6C alkylene or W-(CH2)h-W; h = 2-8; R32+R33 = 3-7-membered heterocycle containing O, S, SO, SO2 or NR34; R34 = H, phenyl, benzyl or 1-4C alkyl. Also claimed are the following intermediates: 3-amino-3-cyclopentyl-1-(4-trifluoromethylphenyl)propenone; 2-cyclopentyl-4-(4-fluorophenyl)-7,7-dimethyl-3-(trifluoromethylbenzoy l)-4,6,7,8-tetrahydro-1H-quinolin-5-one; 2-cyclopentyl-4-(4-fluorophenyl)-7,7-dimethyl-3-(4-trifluoromethylbenz oyl)-7,8-dihydro-6H-quinolin-5-one; Ä2-cyclopentyl-4-(4-fluorophenyl)-5-hydroxy-7,7-dimethyl-5,6,7,8-tetra hydroquinolin-3-ylÜ- (4-trifluoromethylphenyl)-methanone; Ä5-(tert. butyldimethylsilanyloxy)-2-cyclopentyl-4-(4-fluorophenyl)-7,7-dimethyl -5,6,7,8-tetrahydroquinolin-3-ylÜ-(4-trifluoromethylphenyl)-me thanone; Ä5-(tert. butyldimethylsilanyloxy)-2-cyclopentyl-4-(4-fluorophenyl)-7,7-dimethyl -5,6,7,8-tetrahydroquinolin-3-ylÜ-(4-trifluoromethylphenyl)-me thanol; and 5-(tert. butyldimethylsilanyloxy)-2-cyclopentyl-4-(4-fluorophenyl)-3-Äfluoro-(4 -trifluoromethylphenyl)-methylÜ-7,7-dimethyl-5,6,7,8-tetrahydr oquinoline.</description><subject>ACYCLIC OR CARBOCYCLIC COMPOUNDS</subject><subject>ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAININGELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN,SULFUR, SELENIUM OR TELLURIUM</subject><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>1998</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNqFjLEKwkAQRNNYiPoN3gdooRHEctlszGJye9xditiEIGclehD_Hy-Q3mqYeTOzzCJ2WAvUN9BiOssFa3I7ZawgOaekVL4itikgAxY8i060AtsAUusZoVYojRHHE3PJaA-sWV-npaX0ALqYX1pH62zxHF5j2My6yrYleaz2IX76MMbhEd7h2-P9eDjllzPk-f_GD1JaN5Y</recordid><startdate>19980114</startdate><enddate>19980114</enddate><creator>SCHMIDT DELF DR</creator><creator>CONRAD MICHAEL DR</creator><creator>BRANDES ARNDT DR</creator><creator>ANGERBAUER ROLF DR</creator><creator>SCHMECK CARSTEN DR</creator><creator>GIERA HENRY DR</creator><creator>NAAB PAUL DR</creator><creator>BREMM KLAUS DIETER DR</creator><creator>LOGERS MICHAEL DR</creator><creator>MULLER-GLIEMANN MATTHIAS DR</creator><creator>STOLTEFUSS JURGEN</creator><creator>BISCHOFF HILMAR DR</creator><creator>SCHMIDT GUNTER DR</creator><creator>SCHUHMACHER JOACHIM DR</creator><creator>PAULSEN HOLGER DR</creator><scope>EVB</scope></search><sort><creationdate>19980114</creationdate><title>CYCLOALKANOPYRIDINES, PROCESS OF THEIR PREPARATION, PHARMACEUTICAL COMPOSITIONS CONTAINING THEREOF AND THEIR USE</title><author>SCHMIDT DELF DR ; CONRAD MICHAEL DR ; BRANDES ARNDT DR ; ANGERBAUER ROLF DR ; SCHMECK CARSTEN DR ; GIERA HENRY DR ; NAAB PAUL DR ; BREMM KLAUS DIETER DR ; LOGERS MICHAEL DR ; MULLER-GLIEMANN MATTHIAS DR ; STOLTEFUSS JURGEN ; BISCHOFF HILMAR DR ; SCHMIDT GUNTER DR ; SCHUHMACHER JOACHIM DR ; PAULSEN HOLGER DR</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_CZ214397A33</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>cze ; eng</language><creationdate>1998</creationdate><topic>ACYCLIC OR CARBOCYCLIC COMPOUNDS</topic><topic>ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAININGELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN,SULFUR, SELENIUM OR TELLURIUM</topic><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>SCHMIDT DELF DR</creatorcontrib><creatorcontrib>CONRAD MICHAEL DR</creatorcontrib><creatorcontrib>BRANDES ARNDT DR</creatorcontrib><creatorcontrib>ANGERBAUER ROLF DR</creatorcontrib><creatorcontrib>SCHMECK CARSTEN DR</creatorcontrib><creatorcontrib>GIERA HENRY DR</creatorcontrib><creatorcontrib>NAAB PAUL DR</creatorcontrib><creatorcontrib>BREMM KLAUS DIETER DR</creatorcontrib><creatorcontrib>LOGERS MICHAEL DR</creatorcontrib><creatorcontrib>MULLER-GLIEMANN MATTHIAS DR</creatorcontrib><creatorcontrib>STOLTEFUSS JURGEN</creatorcontrib><creatorcontrib>BISCHOFF HILMAR DR</creatorcontrib><creatorcontrib>SCHMIDT GUNTER DR</creatorcontrib><creatorcontrib>SCHUHMACHER JOACHIM DR</creatorcontrib><creatorcontrib>PAULSEN HOLGER DR</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>SCHMIDT DELF DR</au><au>CONRAD MICHAEL DR</au><au>BRANDES ARNDT DR</au><au>ANGERBAUER ROLF DR</au><au>SCHMECK CARSTEN DR</au><au>GIERA HENRY DR</au><au>NAAB PAUL DR</au><au>BREMM KLAUS DIETER DR</au><au>LOGERS MICHAEL DR</au><au>MULLER-GLIEMANN MATTHIAS DR</au><au>STOLTEFUSS JURGEN</au><au>BISCHOFF HILMAR DR</au><au>SCHMIDT GUNTER DR</au><au>SCHUHMACHER JOACHIM DR</au><au>PAULSEN HOLGER DR</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>CYCLOALKANOPYRIDINES, PROCESS OF THEIR PREPARATION, PHARMACEUTICAL COMPOSITIONS CONTAINING THEREOF AND THEIR USE</title><date>1998-01-14</date><risdate>1998</risdate><abstract>Cycloalkano-pyridine compounds of formula (I) and their salts and N-oxides are new. A = 6-10C aryl (optionally up to penta-substituted by halo, NO2, OH, CF3, OCF3, 1-7C alkyl, 1-7C acyl, 1-7C hydroxyalkyl, 1-7C alkoxy or NR3R4); R3, R4 = H, phenyl or 1-6C alkyl; D = 6-10C aryl (optionally substituted by phenyl, halo, NO2, CF3 or OCF3), LR5, C(R6)(R7)R8 or XVTR9; R9 = 3-6C cycloalkyl, 6-10C aryl or 5-7 membered, optionally benzo-condensed, optionally unsaturated mono- bi or tri-cyclic heterocycle with 1-4 S, N and/or O (all optionally up to penta-substituted by halo, NO2, OH, CF3, CN, COOH, OCF3, 1-6C alkyl, 1-6C acyl, 1-6C alkylthio, 1-6C alkoxy or alkoxycarbonyl, 6-10C aryl (optionally substituted by aryl or CF3) or 5-7 membered, optionally benzo-condensed, heteroaryl with 1-3 N, O and/or S heteroatoms), and/or OR10, SR11, SO2R12 or NR13, R14; R10-R12 = 6-10C aryl (optionally mono- to di-substituted, by phenyl, halo or 1-6C alkyl); R5, R6 = as for R9 or a group of formula (a) or (b); R7 = H or halo; R8 = H, halo, N3, CF3, OH, OCF3, 1-6C alkoxy, 1-6C alkyl or NR15R16; or R7+R8 = O or NR17; R17 = H, 1-6C alkyl, 1-6C acyl or 1-6C alkoxy; L = 1-8C alkylene or 2-8C alkenylene (both optionally mono- or di- substituted by OH); T, X = bond or 1-8C alkylene, provided they are not both a bond; V = O, S or NR18; R13-R16, R18 = as R3, R4; E = 3-8C cycloalkyl, 1-8C alkyl (optionally substituted by 3-8C cycloalkyl or OH) or phenyl (optionally substituted by halo or CF3); R1+R2 = 1-7C alkylene substituted by carbonyl and/or Z, and optionally also geminal, optionally substituted by up to 6 Z' and/or up to 5 Z", and/or 1,2-(CH2)c, SO2C6H5, (CO)dNR23R24 or O; and/or a spiro-bonded group Zb of formula (g)-(k); Z = OR19, or a group of formula (c)-(f); a, b = 1-3; R19 = H, 3-7C cycloalkyl, up to 8C silylalkyl, 1-8C alkyl (optionally substituted by OH, 1-6C alkoxy or Ar), (where alkyl is optionally substituted by OR22) ÄsicÜ, 1-20C acyl or benzoyl (optionally substituted by halo, CF3, NO2 or OCF3) or 1-8C fluoroacyl (with 1-9F); R20, R21 = H, phenyl or 1-6C alkyl; or R20+R21 = 3-6C cycloalkyl; Z" = phenyl, benzoyl, thiophenyl or sulphonylbenzyl (all optionally substituted by halo, CF3, OCF3 or NO2); Z' = halo, NO2, N3, OH, CF3, CN, NC, COOH, 3-7C cycloalkyl, 3-7C cycloalkyloxy, 1-6C alkyl (optionally mono- or di-substituted by OH, benzyloxy, CF3, benzoyl, alkoxy, oxyacyl or carboxy each with 1-4C, and/or phenyl (itself optionally substituted by halo, CF3 or OCF3)), 1-6C alkylthio, 1-6C alkoxy or alkoxycarbonyl; R22 = 1-4C acyl or benzyl; Ar = phenyl (optionally substituted by halo, NO2, CF3, OCF3 or phenyl- or tetrazolyl-substituted phenyl); c = 1-4; d = 0 or 1; R23, R24 = H, 3-6C cycloalkyl, 1-6C alkyl, benzyl or phenyl (optionally mono- or di-substituted by halo, CF3, CN, phenyl or NO2); W= O or S; Y+Y' = 2-6C alkylene; e = 1-7; f = 1 or 2; R25-R31 = H, CF3, phenyl, halo, 1-6C alkyl or 1-6C alkoxy; or R25+R26 or R27+R28 = 1-6C alkylene or W-(CH2)h-W; h = 2-8; R32+R33 = 3-7-membered heterocycle containing O, S, SO, SO2 or NR34; R34 = H, phenyl, benzyl or 1-4C alkyl. Also claimed are the following intermediates: 3-amino-3-cyclopentyl-1-(4-trifluoromethylphenyl)propenone; 2-cyclopentyl-4-(4-fluorophenyl)-7,7-dimethyl-3-(trifluoromethylbenzoy l)-4,6,7,8-tetrahydro-1H-quinolin-5-one; 2-cyclopentyl-4-(4-fluorophenyl)-7,7-dimethyl-3-(4-trifluoromethylbenz oyl)-7,8-dihydro-6H-quinolin-5-one; Ä2-cyclopentyl-4-(4-fluorophenyl)-5-hydroxy-7,7-dimethyl-5,6,7,8-tetra hydroquinolin-3-ylÜ- (4-trifluoromethylphenyl)-methanone; Ä5-(tert. butyldimethylsilanyloxy)-2-cyclopentyl-4-(4-fluorophenyl)-7,7-dimethyl -5,6,7,8-tetrahydroquinolin-3-ylÜ-(4-trifluoromethylphenyl)-me thanone; Ä5-(tert. butyldimethylsilanyloxy)-2-cyclopentyl-4-(4-fluorophenyl)-7,7-dimethyl -5,6,7,8-tetrahydroquinolin-3-ylÜ-(4-trifluoromethylphenyl)-me thanol; and 5-(tert. butyldimethylsilanyloxy)-2-cyclopentyl-4-(4-fluorophenyl)-3-Äfluoro-(4 -trifluoromethylphenyl)-methylÜ-7,7-dimethyl-5,6,7,8-tetrahydr oquinoline.</abstract><edition>6</edition><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | cze ; eng |
| recordid | cdi_epo_espacenet_CZ214397A3 |
| source | esp@cenet |
| subjects | ACYCLIC OR CARBOCYCLIC COMPOUNDS ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAININGELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN,SULFUR, SELENIUM OR TELLURIUM CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
| title | CYCLOALKANOPYRIDINES, PROCESS OF THEIR PREPARATION, PHARMACEUTICAL COMPOSITIONS CONTAINING THEREOF AND THEIR USE |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-20T10%3A12%3A50IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=SCHMIDT%20DELF%20DR&rft.date=1998-01-14&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3ECZ214397A3%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |